Impact of non-selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score.
Ting WangXueying WangSiqi JiaHaitao ZhaoLe WangXianxian ZhangXiaohui FangYong HeHongyu LiFrank TackeXing Shun QiPublished in: Alimentary pharmacology & therapeutics (2024)
NSBBs may be beneficial for the prevention of further decompensation in cirrhotic patients with a MELD score of ≤9, but deleterious in those with a MELD score of >9.